Clinical Sales Specialist 2 – Brazil

Brazil

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, HealthcareIndustries

Requirements

Candidates must possess a Bachelor's degree in Life Sciences or a related field, with a postgraduate degree being a plus. A minimum of 3 years of experience in molecular diagnostics sales or a related field is required. Fluency in both Portuguese and English, with excellent written and verbal communication skills, is essential. A strong understanding of the healthcare sector, trends, and opportunities is necessary, as is a proven ability to develop and expand key accounts. Preferred qualifications include a technical background in molecular biology or genomics, excellent listening, organizational, negotiation, and time management skills, and a collaborative, adaptable, and results-oriented professional attitude.

Responsibilities

The Clinical Sales Specialist will support Illumina’s business growth and strengthen partnerships with clinical customers throughout São Paulo, Brazil. They will collaborate with Territory Account Managers (TAMs) to develop customer accounts, create territory plans, and understand clinical and economic trends. Responsibilities include analyzing the competitive landscape, sharing technical and product knowledge, and planning sales activities. The specialist will prepare and deliver sales presentations in Portuguese and English, support new technology introductions, and provide feedback to management. They will maintain customer information in the CRM, identify growth opportunities, and provide sales forecasts. Additionally, they will interpret scientific publications, represent Illumina at events, and serve as a communication point between the company and its customers.

Skills

Genomics

Clinical Sales

Relationship-based sales

Territory planning

Competitive analysis

English fluency

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free